Cell transfer therapy of cancer metastasis with autologous lymphocytes.
Mikamo
S
S
Department of Clinical Oncology, University of Tokyo, Japan.
Sekiguchi
M
M
D015703:Antigens, CD / Q000032:analysis; D017252:CD3 Complex / Q000032:analysis; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002478:Cells, Cultured; D005434:Flow Cytometry; D006801:Humans; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology*; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy; D008213:Lymphocyte Activation; D017710:Lymphocyte Transfusion; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000473:pathology* / Q000628:therapy*; D010166:Palliative Care; D012004:Rectal Neoplasms / Q000628:therapy; D012008:Recurrence; D014182:Transplantation, Autologous
D015703:Antigens, CD; D017252:CD3 Complex